Pharmacokinetics, Safety and Tolerability of Crinecerfont in Participants With Congenital Adrenal Hyperplasia Who Are Less Than 2 Years Old
Clinical trial NCT07187375 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT07187375
- Sponsor
- Neurocrine Biosciences
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2025-09-30
- Primary completion
- 2029-09-06
- Enrollment
- 7
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.